Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Home

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Diabetologia|January 5, 2019
Cardiovascular outcome trials of glucose-lowering medications: an updatePhilip Home
Metabolism: Clinical and Experimental|September 18, 2021
Future directions in insulin therapyPhilip Home
Diabetes Technology & Therapeutics|June 2, 2012
Cardiovascular disease and oral agent glucose-lowering therapies in the management of type 2 diabetesPhilip Home
Diabetes Care|June 10, 2019
Controversies for Glucose Control Targets in Type 2 Diabetes: Exposing the Common GroundPhilip Home
Current Medical Research and Opinion|July 12, 2005
Contributions of basal and post-prandial hyperglycaemia to micro- and macrovascular complications in people with type 2 diabetesPhilip Home
The Journal of the Royal College of Physicians of Edinburgh|May 18, 2023
Insulin biobetters and biosimilars in clinical practicePhilip Home
Diabetes Research and Clinical Practice|April 16, 2021
The evolution of insulin therapyPhilip Home
Expert Opinion on Pharmacotherapy|February 2, 2006
Insulin detemir: from concept to clinical experiencePhilip Home, Peter Kurtzhals
Diabetes Research and Clinical Practice|May 6, 2021
Heart failure management; a perspective from diabetes careBaruch Itzhak, Philip Home
American Journal of Therapeutics|October 1, 2019
Is Insulin Therapy Safe?Philip Home, Baruch Itzhak
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Diabetologia|January 5, 2019
Cardiovascular outcome trials of glucose-lowering medications: an updatePhilip Home
Metabolism: Clinical and Experimental|September 18, 2021
Future directions in insulin therapyPhilip Home
Diabetes Technology & Therapeutics|June 2, 2012
Cardiovascular disease and oral agent glucose-lowering therapies in the management of type 2 diabetesPhilip Home
Diabetes Care|June 10, 2019
Controversies for Glucose Control Targets in Type 2 Diabetes: Exposing the Common GroundPhilip Home
Current Medical Research and Opinion|July 12, 2005
Contributions of basal and post-prandial hyperglycaemia to micro- and macrovascular complications in people with type 2 diabetesPhilip Home
The Journal of the Royal College of Physicians of Edinburgh|May 18, 2023
Insulin biobetters and biosimilars in clinical practicePhilip Home
Diabetes Research and Clinical Practice|April 16, 2021
The evolution of insulin therapyPhilip Home
Expert Opinion on Pharmacotherapy|February 2, 2006
Insulin detemir: from concept to clinical experiencePhilip Home, Peter Kurtzhals
Diabetes Research and Clinical Practice|May 6, 2021
Heart failure management; a perspective from diabetes careBaruch Itzhak, Philip Home
American Journal of Therapeutics|October 1, 2019
Is Insulin Therapy Safe?Philip Home, Baruch Itzhak
Pageof 5